Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Clinical and Experimental Dermatology, 3(22), p. 146-147, 1997

DOI: 10.1111/j.1365-2230.1997.tb01044.x

Wiley, Clinical and Experimental Dermatology, 03(22), p. 146-147, 1997

DOI: 10.1046/j.1365-2230.1997.2190648.x

Links

Tools

Export citation

Search in Google Scholar

Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor

Journal article published in 1997 by P. Jarrett, M. Rademaker ORCID, J. Havill, H. Pullon
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

A patient developed toxic epidermal necrolysis while on carbamazepine, 80% of her skin surface being involved. She also developed a pancytopenia with a neutropenia of 0.77 x 10(9)/l (normal range 2-7.5 x 10(9)/l), but was treated with cyclosporin and granulocyte colony stimulating factor and made a full recovery.